Requires the Department of Human Services to provide Medicaid and Medicare part D prescription drug program recipients with coverage of glucagon-like peptide-1 (GLP-1) drugs for weight loss. Appropriates funds.
- Chamber
- Senate
- Introduced
- Jan 28, 2026
- Last action
- Jan 28, 2026 — Introduced.
- Session
- 2026
- Momentum
- 35 · Low